Skip to Main Content

Author Details

Robert F Garry
Tulane University School of Medicine
1974
282
53
PMIDPaper TitleJournal TitlePublished Year
3245815150 Years of Lassa Fever Research.Curr Top Microbiol Immunol2023
37590417A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus.Proc Natl Acad Sci U S A2023
37849403The Arenaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens.J Infect Dis2023
37745602Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic.bioRxiv2023
36993465Novel Tools for Lassa Virus Surveillance in Peri-domestic Rodents.medRxiv2023
37106159Lassa Fever Natural History and Clinical Management.Curr Top Microbiol Immunol2023
37100973Lassa Virus Structural Biology and Replication.Curr Top Microbiol Immunol2023
36996258A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.PLoS One2023
36758101Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study.PLoS Negl Trop Dis2023
36097163Lassa fever - the road ahead.Nat Rev Microbiol2023
34986351Ebola virus delta peptide is an enterotoxin.Cell Rep2022
35613585Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies.Cell Rep2022
35730904Neutralizing Antibodies against Lassa Virus Lineage I.mBio2022
36441765Expansion of CD8+ T cell population in Lassa virus survivors with low T cell precursor frequency reveals durable immune response in most survivors.PLoS Negl Trop Dis2022
36567369Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in Southern Nigeria.Sci Rep2022
36146799Evaluation of Virulence in Cynomolgus Macaques Using a Virus Preparation Enriched for the Extracellular Form of Monkeypox Virus.Viruses2022
36173950SARS-CoV-2 furin cleavage site was not engineered.Proc Natl Acad Sci U S A2022
36355862The evidence remains clear: SARS-CoV-2 emerged via the wildlife trade.Proc Natl Acad Sci U S A2022
36016363Effect of Monkeypox Virus Preparation on the Lethality of the Intravenous Cynomolgus Macaque Model.Viruses2022
36288283A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus.Sci Transl Med2022
35881010The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic.Science2022
35881005The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2.Science2022
35215114Enterotoxigenic <i>Escherichia coli</i> Heat-Stable Toxin and Ebola Virus Delta Peptide: Similarities and Differences.Pathogens2022
34931078Role of the T cell vitamin D receptor in severe COVID-19.Nat Immunol2022
34260615Health seeking behavior after the 2013-16 Ebola epidemic: Lassa fever as a metric of persistent changes in Kenema District, Sierra Leone.PLoS Negl Trop Dis2021
33852832A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus.Immunity2021
33822010Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone.Clin Infect Dis2021
33809204Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012-2019.Microorganisms2021
34526683Ebola virus can lie low and reactivate after years in human survivors.Nature2021
34578352Zika Virus Non-Structural Protein 1 Antigen-Capture Immunoassay.Viruses2021
34835131Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans.Viruses2021
34508652Emergence of an early SARS-CoV-2 epidemic in the United States.Cell2021
34480864The origins of SARS-CoV-2: A critical review.Cell2021
34452470The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and Response.Viruses2021
34102313Ct Values Do Not Predict Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmissibility in College Students.J Mol Diagn2021
34242218Implementation of the Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) study: Lessons learned for vision health systems strengthening in Sierra Leone.PLoS One2021
34237771After the pandemic: perspectives on the future trajectory of COVID-19.Nature2021
34201591Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail.Viruses2021
34311743Retraction Note: Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypes.Virol J2021
31301137Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses.J Infect Dis2020
33079033Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever.Emerg Infect Dis2020
33243278Elevated L-threonine is a biomarker for Lassa fever and Ebola.Virol J2020
33241780Lassa Fever among Children in Eastern Province, Sierra Leone: A 7-year Retrospective Analysis (2012-2018).Am J Trop Med Hyg2020
32807807Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time.Nat Commun2020
32994446Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.Sci Rep2020
32907984Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.J Virol2020
32418788Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition &amp; guidelines for data collection, analysis, and presentation of immunization safety data.Vaccine2020
32120884Proteomics Computational Analyses Suggest That the Envelope Glycoproteins of Segmented Jingmen Flavi-Like Viruses are Class II Viral Fusion Proteins (b-Penetrenes) with Mucin-Like Domains.Viruses2020
32436943Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae.J Infect Dis2020
32142546High crossreactivity of human T cell responses between Lassa virus lineages.PLoS Pathog2020
  • 1 - 50 of 282

Recommended Authors

CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2003
Number of shared co-authors 1
University of Toledo
Career Start Year 2002
Number of shared co-authors 1
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 3
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 4
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 7
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 12
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 10
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 3
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1992
Number of shared co-authors 1
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 6
University of Manitoba
Career Start Year 1991
Number of shared co-authors 24
School of Public Health, University of California berkeley
Career Start Year 1990
Number of shared co-authors 2
Institute of Virology, Medical Center - University of Freiburg
Career Start Year 1989
Number of shared co-authors 8
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 24
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 3
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 25
Ben-Gurion University of the Negev
Career Start Year 1984
Number of shared co-authors 24
University of Texas Medical Branch
Career Start Year 1983
Number of shared co-authors 4
Max-von-Pettenkofer Institute, Ludwig-Maximilians-University (LMU) Munich
Career Start Year 1983
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 0
University of North Carolina
Career Start Year 1981
Number of shared co-authors 14
Rockefeller University
Career Start Year 1981
Number of shared co-authors 7
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 5
Carver College of Medicine, University of Iowa
Career Start Year 1978
Number of shared co-authors 2
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 4
Center for Family Health Research Zambia
Career Start Year 1971
Number of shared co-authors 1
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 5
Stanford University School of Medicine
Career Start Year 1960
Number of shared co-authors 2

Collaborators

Tulane University
Co-authored papers 45
Harvard University
Co-authored papers 29
Broad Institute of MIT and Harvard
Co-authored papers 12
Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard
Co-authored papers 12
London School of Hygiene & Tropical Medicine
Co-authored papers 10
Co-authored papers 9
Institute of Ecology and Evolution, University of Edinburgh
Co-authored papers 8
Sydney Institute for Infectious Diseases, The University of Sydney
Co-authored papers 7
the Scripps Research Institute
Co-authored papers 7
The Scripps Research Institute
Co-authored papers 6
The Center for Genome Architecture, Baylor College of Medicine
Co-authored papers 6
The Scripps Research Institute
Co-authored papers 6
University of Massachusetts Medical School
Co-authored papers 5
University of California los angeles
Co-authored papers 5
University of Arizona
Co-authored papers 4
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 4
Broad Institute of MIT and Harvard
Co-authored papers 4
University of Texas Medical Branch at Galveston
Co-authored papers 4
University of California
Co-authored papers 4
Rega Institute, Laboratory of Clinical and Evolutionary Virology
Co-authored papers 4
Yale School of Public Health
Co-authored papers 3
Rega Institute, University of Leuven
Co-authored papers 3
Erasmus Medical Center
Co-authored papers 3
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 3
University of California berkeley
Co-authored papers 3
University of California San Diego
Co-authored papers 3
Co-authored papers 3
University of Texas Medical Branch
Co-authored papers 3
Co-authored papers 3
Christchurch Hospital
Co-authored papers 3